Literature DB >> 15764175

Timeliness of case reporting in the Swedish statutory surveillance of communicable diseases 1998--2002.

Anna Jansson1, Malin Arneborn, Katarina Skärlund, Karl Ekdahl.   

Abstract

To prepare for a new communicable disease act in Sweden, we performed an in-depth analysis of the performance of the present notification system (1998--2002). Four diseases were selected for analysis (meningococcal infection, salmonellosis, infection with penicillin-resistant pneumococci and tularaemia). Each step in the double notification flow (clinical and laboratory notifications) was studied and paper-based and electronic notifications compared. More than 15 possible single dates in the notification flows were analysed for 27,000 cases. The shortest notification flows (from date of sample collection to when the first notification was received at SMI--clinical or laboratory notification) were seen for meningococcal infections and salmonellosis (median 7 d) and the longest for tularaemia (11 d). Laboratory notifications were faster than clinical notifications, and electronic reporting 1.5-1.7 times faster than paper notifications. Further gains should be expected from the new electronic reporting system (SmiNet2), which will allow also clinical reporting electronically over the internet.

Entities:  

Mesh:

Year:  2004        PMID: 15764175     DOI: 10.1080/00365540410025348

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  14 in total

1.  Feasibility of implementing recommendations to improve communicable diseases surveillance--a modified Delphi study.

Authors:  N Sahal; R Reintjes; E M Eltayeb; A R Aro
Journal:  Afr Health Sci       Date:  2011-08       Impact factor: 0.927

2.  An evaluation and comparison of three commonly used statistical models for automatic detection of outbreaks in epidemiological data of communicable diseases.

Authors:  P Rolfhamre; K Ekdahl
Journal:  Epidemiol Infect       Date:  2005-12-22       Impact factor: 2.451

3.  A 5-year comparison of performance of sentinel and mandatory notification surveillance systems for measles in Switzerland.

Authors:  Jean-Luc Richard; Beatriz Vidondo; Mirjam Mäusezahl
Journal:  Eur J Epidemiol       Date:  2007-09-26       Impact factor: 8.082

4.  Completeness and timeliness of Salmonella notifications in Ireland in 2008: a cross sectional study.

Authors:  Nathalie Nicolay; Patricia Garvey; Niall Delappe; Martin Cormican; Paul McKeown
Journal:  BMC Public Health       Date:  2010-09-22       Impact factor: 3.295

5.  Australia's National Notifiable Diseases Surveillance System 1991-2011: expanding, adapting and improving.

Authors:  K B Gibney; A C Cheng; R Hall; K Leder
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

6.  Comprehensive effective and efficient global public health surveillance.

Authors:  Scott J N McNabb
Journal:  BMC Public Health       Date:  2010-12-03       Impact factor: 3.295

7.  Analysis of timeliness of infectious disease reporting in the Netherlands.

Authors:  Elisabeth Reijn; Corien M Swaan; Mirjam E E Kretzschmar; Jim E van Steenbergen
Journal:  BMC Public Health       Date:  2011-05-30       Impact factor: 3.295

8.  Endemic tularemia, Sweden, 2003.

Authors:  Lara Payne; Malin Arneborn; Anders Tegnell; Johan Giesecke
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

9.  Evaluating the Timeliness of Enteric Disease Surveillance in British Columbia, Canada, 2012-13.

Authors:  Eleni Galanis; Marsha Taylor; Kamila Romanowski; Olga Bitzikos; Jennifer Jeyes; Craig Nowakowski; Jason Stone; Michelle Murti; Ana Paccagnella; Sara Forsting; Sophie Li; Linda Hoang
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-06-01       Impact factor: 2.471

10.  Timeliness of national notifiable diseases surveillance system in Korea: a cross-sectional study.

Authors:  Hyo-Soon Yoo; Ok Park; Hye-Kyung Park; Eun-Gyu Lee; Eun-Kyeong Jeong; Jong-Koo Lee; Sung-Il Cho
Journal:  BMC Public Health       Date:  2009-03-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.